Medicare Enrolled
Dr. Viral Shah, M.D.
Endocrinology · Paramus, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shah?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shah
Dr. Viral Shah is an endocrinology specialist in Paramus, NJ, with 18 years of NPI registration. Based on federal Medicare data, Dr. Shah performed 1,154 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Shah received a total of $57,536 from 65 pharmaceutical and/or device companies across 806 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shah is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 40% volume in NJ
$57,536 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,154
Medicare services
Top 40% in NJ for endocrinology
Not available
Unique patients (not deduplicated)
$116
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
575 | $110 | $410 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
156 | $104 | $320 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
115 | $137 | $567 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
115 | $150 | $697 |
| New patient office visit, complex (60-74 min) | 107 | $184 | $690 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
44 | $0 | $2 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
42 | $30 | $535 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$57,536
Total received (2018-2024)
Avg $8,219/year across 7 years
Top 7% in NJ for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
65
Companies
806
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,718
2023
$1,455
2022
$14,130
2021
$12,985
2020
$12,803
2019
$7,889
2018
$4,556
Payments by company (2024)
Dexcom, Inc.
$2,012
Medtronic, Inc.
$240
Amgen Inc.
$212
Lilly USA, LLC
$209
Tandem Diabetes Care, Inc.
$130
Corcept Therapeutics
$87
Antares Pharma, Inc.
$87
ABBVIE INC.
$82
Amneal Pharmaceuticals LLC
$67
Abbott Laboratories
$64
SANOFI-AVENTIS U.S. LLC
$53
Intra-Sana Laboratories
$46
Bayer Healthcare Pharmaceuticals Inc.
$40
Xeris Pharmaceuticals, Inc.
$39
Radius Health, Inc.
$33
Verity Pharmaceuticals Inc.
$33
RECORDATI_RARE_DISEASES_INC.
$31
Mannkind Corporation
$31
Acella Pharmaceuticals, LLC
$28
Novo Nordisk Inc
$26
Astellas Pharma US Inc
$21
CeQur Corporation
$20
IBSA Pharma Inc.
$20
Insulet Corporation
$17
Alexion Pharmaceuticals, Inc.
$16
Kyowa Kirin, Inc.
$16
Echosens North America, Inc.
$16
Neurocrine Biosciences, Inc.
$15
Chiesi USA, Inc.
$15
AstraZeneca Pharmaceuticals LP
$14
Top 3 companies account for 66.3% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$19,975
Dexcom, Inc.
$13,997
DEXCOM, INC.
$7,976
Janssen Pharmaceuticals, Inc
$5,351
Novo Nordisk Inc
$1,379
Lilly USA, LLC
$1,193
Amgen Inc.
$986
Corcept Therapeutics
$686
Amneal Pharmaceuticals LLC
$656
Abbott Laboratories
$600
SANOFI-AVENTIS U.S. LLC
$594
Medtronic, Inc.
$344
AbbVie, Inc.
$337
Mannkind Corporation
$279
Insulet Corporation
$263
Antares Pharma, Inc.
$249
Merck Sharp & Dohme Corporation
$212
Xeris Pharmaceuticals, Inc.
$189
Boehringer Ingelheim Pharmaceuticals, Inc.
$178
Radius Health, Inc.
$134
Tandem Diabetes Care, Inc.
$130
Esperion Therapeutics, Inc.
$125
Aytu BioScience, Inc
$121
CeQur Corporation
$117
ABBVIE INC.
$111
Bayer Healthcare Pharmaceuticals Inc.
$76
Intra-Sana Laboratories
$73
Merck Sharp & Dohme LLC
$72
IBSA Pharma Inc.
$62
Zealand Pharma US, Inc.
$62
VIVUS, Inc.
$60
Astellas Pharma US Inc
$60
Medtronic MiniMed, Inc.
$60
Supernus Pharmaceuticals, Inc.
$52
Kyowa Kirin, Inc.
$49
Alexion Pharmaceuticals, Inc.
$48
Gemini Laboratories, LLC
$45
Valeritas, Inc.
$45
Embecta Corp.
$42
Amryt Pharma Holdings Ltd
$40
PFIZER INC.
$39
Ascendis Pharma Inc
$35
Verity Pharmaceuticals Inc.
$33
RECORDATI_RARE_DISEASES_INC.
$31
Acella Pharmaceuticals, LLC
$28
Horizon Therapeutics plc
$28
Amarin Pharma Inc.
$26
EISAI INC.
$24
Genentech USA, Inc.
$24
Novartis Pharmaceuticals Corporation
$24
Echosens North America, Inc.
$20
Currax Pharmaceuticals LLC
$17
Azurity Pharmaceuticals, Inc.
$15
MannKind Corporation
$15
AbbVie Inc.
$15
Neurocrine Biosciences, Inc.
$15
Chiesi USA, Inc.
$15
Becton, Dickinson and Company
$15
Kowa Pharmaceuticals America, Inc.
$14
Ultragenyx Pharmaceutical Inc.
$14
LifeScan, Inc.
$13
Clarus Therapeutics Inc.
$13
Aytu Bioscience, Inc
$13
Allergan Inc.
$12
Eisai Inc.
$12
Top 3 companies account for 72.9% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Adthyza · Androgel · BAQSIMI · BASAGLAR · BD Nano 2nd Gen Pen Needle · BD Ultra-Fine · BELSOMRA · BYSTOLIC · Belviq · CONTRAVE · CRYSVITA · CeQur Simplicity · Creon · Crysvita · DEXCOM CGM · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · FARXIGA · FORTEO · FREESTYLE INSULINX · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FibroScan · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMALOG · HUMULIN · INVOKANA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · LICART · LIVALO · Lenvima · MINIMED 780G · MOUNJARO · MYALEPT · MYCAPSSA · Minimed 670G System · NEXLIZET · NOCDURNA · NP Thyroid 60 · Natesto · OTREXUP · Omnipod · OneTouch · Otrexup · Ozempic · PRALUENT · Prolia · QSYMIA · RECORLEV · RELTONE 200 MG · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STEGLATRO · STEGLUJAN · STRENSIQ · SYNTHROID · Saxenda · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tlando · Tresiba · Tymlos · UNITHROID · V-GO · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · ZEPBOUND · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Endocrinologists in nearby ZIP areas
629
County median income
$123,715
Nearest hospital to ZIP centroid (approximate)
VALLEY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shah is a clinical cardiology specialist, with moderate Medicare volume, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shah experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Shah performed 575 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Shah receive payments from pharmaceutical companies?
Yes. Dr. Shah received a total of $57,536 from 65 companies across 806 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shah's costs compare to other endocrinologists in Paramus?
Dr. Shah's average Medicare payment per service is $116. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Paramus
Browse endocrinologists in Paramus ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in NJ
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in NJ
Which NJ endocrinologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Dexcom, Inc. Payments to Doctors
See all physicians who received payments from Dexcom, Inc.
By company
DEXCOM, INC. Payments to Doctors
See all physicians who received payments from DEXCOM, INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology